People

Andrew J. Perlman, published as Andy Perlman in Avestria’s adviser directory, is a physician-scientist with drug-development experience. His biography identifies co-founding work at AI drug-discovery company X-37 and Velocity Pharmaceutical Development, and earlier roles at Tularik, Genentech, Innate Immune and Affymax. He studied physics at MIT and medicine and science at NYU.